Alkermes
ALKS
#3178
Rank
C$6.78 B
Marketcap
C$41.06
Share price
-2.05%
Change (1 day)
-16.48%
Change (1 year)

P/S ratio for Alkermes (ALKS)

P/S ratio as of February 2026 (TTM): 3.27

According to Alkermes's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 2.87. At the end of 2025 the company had a P/S ratio of 3.03.

P/S ratio history for Alkermes from 2001 to 2025

PS ratio at the end of each year

Year P/S ratio Change
20253.03-1.41%
20243.0710.3%
20232.78-27.93%
20223.8620.51%
20213.204.84%
20203.0611.2%
20192.75-34.56%
20184.20-54.91%
20179.32-17.75%
201611.3-40.5%
201519.036.36%
201414.075.6%
20137.9575.93%
20124.52-37.59%
20117.247.63%
20106.7339.1%
20094.8464.83%
20082.93-54.39%
20076.439.05%
20065.90-54.2%
200512.9-29.98%
200418.4-46.02%
200334.1298.68%
20028.55-74.14%
200133.1

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
Johnson & Johnson
JNJ
6.49 98.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
5.78 77.01%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
2.49-23.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
2.47-24.57%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
2.65-18.86%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
5.59 71.10%๐Ÿ‡ฌ๐Ÿ‡ง UK
Zogenix
ZGNX
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
0.0071-99.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
2.24-31.47%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel